scholarly journals Intracellular Localization and Conformational State of Transglutaminase 2: Implications for Cell Death

PLoS ONE ◽  
2009 ◽  
Vol 4 (7) ◽  
pp. e6123 ◽  
Author(s):  
Soner Gundemir ◽  
Gail V. W. Johnson
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Rahima Chennoufi ◽  
Ngoc-Duong Trinh ◽  
Françoise Simon ◽  
Guillaume Bordeau ◽  
Delphine Naud-Martin ◽  
...  

Molecules ◽  
2019 ◽  
Vol 24 (24) ◽  
pp. 4477 ◽  
Author(s):  
Vladimíra Pavlíčková ◽  
Silvie Rimpelová ◽  
Michal Jurášek ◽  
Kamil Záruba ◽  
Jan Fähnrich ◽  
...  

Purpurin 18 derivatives with a polyethylene glycol (PEG) linker were synthesized as novel photosensitizers (PSs) with the goal of using them in photodynamic therapy (PDT) for cancer. These compounds, derived from a second-generation PS, exhibit absorption at long wavelengths; considerable singlet oxygen generation and, in contrast to purpurin 18, have higher hydrophilicity due to decreased logP. Together, these properties make them potentially ideal PSs. To verify this, we screened the developed compounds for cell uptake, intracellular localization, antitumor activity and induced cell death type. All of the tested compounds were taken up into cancer cells of various origin and localized in organelles known to be important PDT targets, specifically, mitochondria and the endoplasmic reticulum. The incorporation of a zinc ion and PEGylation significantly enhanced the photosensitizing efficacy, decreasing IC50 (half maximal inhibitory compound concentration) in HeLa cells by up to 170 times compared with the parental purpurin 18. At effective PDT concentrations, the predominant type of induced cell death was apoptosis. Overall, our results show that the PEGylated derivatives presented have significant potential as novel PSs with substantially augmented phototoxicity for application in the PDT of cervical, prostate, pancreatic and breast cancer.


FEBS Letters ◽  
2005 ◽  
Vol 579 (15) ◽  
pp. 3297-3302 ◽  
Author(s):  
László Fésüs ◽  
Zsuzsa Szondy

2005 ◽  
Vol 4 (9) ◽  
pp. 1293-1302 ◽  
Author(s):  
Liya Yuan ◽  
Kihang Choi ◽  
Chaitan Khosla ◽  
Xiao Zheng ◽  
Ryuji Higashikubo ◽  
...  

Cells ◽  
2021 ◽  
Vol 10 (7) ◽  
pp. 1842
Author(s):  
Hideki Tatsukawa ◽  
Kiyotaka Hitomi

Transglutaminase 2 (TG2) is a ubiquitously expressed enzyme catalyzing the crosslinking between Gln and Lys residues and involved in various pathophysiological events. Besides this crosslinking activity, TG2 functions as a deamidase, GTPase, isopeptidase, adapter/scaffold, protein disulfide isomerase, and kinase. It also plays a role in the regulation of hypusination and serotonylation. Through these activities, TG2 is involved in cell growth, differentiation, cell death, inflammation, tissue repair, and fibrosis. Depending on the cell type and stimulus, TG2 changes its subcellular localization and biological activity, leading to cell death or survival. In normal unstressed cells, intracellular TG2 exhibits a GTP-bound closed conformation, exerting prosurvival functions. However, upon cell stimulation with Ca2+ or other factors, TG2 adopts a Ca2+-bound open conformation, demonstrating a transamidase activity involved in cell death or survival. These functional discrepancies of TG2 open form might be caused by its multifunctional nature, the existence of splicing variants, the cell type and stimulus, and the genetic backgrounds and variations of the mouse models used. TG2 is also involved in the phagocytosis of dead cells by macrophages and in fibrosis during tissue repair. Here, we summarize and discuss the multifunctional and controversial roles of TG2, focusing on cell death/survival and fibrosis.


Author(s):  
Mauro Piacentini ◽  
Manuela D'Eletto ◽  
Laura Falasca ◽  
Maria Grazia Farrace ◽  
Carlo Rodolfo

Blood ◽  
2018 ◽  
Vol 132 (20) ◽  
pp. 2183-2187 ◽  
Author(s):  
Shigeharu Ueki ◽  
Takahiro Tokunaga ◽  
Rossana C. N. Melo ◽  
Hidekazu Saito ◽  
Kohei Honda ◽  
...  

Abstract Protein crystallization in human tissue rarely occurs. Charcot-Leyden crystals (CLCs) were described in various eosinophilic diseases >150 years ago, but our understanding of CLC formation still remains limited. In this study, we demonstrate that CLCs observed in varied inflamed human tissues are closely associated with eosinophil cell-free granules and nuclear envelope/plasma membrane disintegration with release of filamentous chromatin (extracellular traps), typical morphologies of a regulated pathway of extracellular trap cell death (ETosis). During the process of eosinophil ETosis, eccentrically localized cytoplasmic and perinuclear CLC protein (galectin-10) is homogeneously redistributed in the cytoplasm. Rapid (1-2 minutes) formation of intracytoplasmic CLCs was observed using time-lapse imaging. Plasma membrane rupture enabled the release of both intracellularly formed CLCs and soluble galectin-10 that further contributed to formation of CLCs extracellularly, in parallel with the expulsion of free intact granules and extracellular traps. CLC formation and galectin-10 release were dependent on nicotinamide adenine dinucleotide phosphate oxidase activation. To our knowledge, this is the first demonstration of natural formation of CLCs in association with an active physiological process (ie, ETosis). These results indicate that dynamic changes in intracellular localization and release of galectin-10 contribute to CLC formation in vivo and suggest that CLC/galectin-10 might serve as an indicator of ETosis.


2012 ◽  
Vol 33 (3) ◽  
pp. 235-241 ◽  
Author(s):  
Sung-Yup Cho ◽  
Eui Man Jeong ◽  
Jin-Haeng Lee ◽  
Hyo-Jun Kim ◽  
Jisun Lim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document